Novo Nordisk’s oral diabetes drug safe and effective
June 12, 2019Research and Development GLP-1, Novo Nordisk, diabetes, pharma, samgalutide
Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results …
First case of Ebola recorded in Uganda
June 12, 2019Research and Development
Ebola has spread to Uganda, according to the WHO. A five year old boy has been infected with the Ebola …
MPs discuss breaking Vertex’s IP rights to bring Orkambi to UK
June 11, 2019Research and Development Orkambi, Vertex, access, house of commons, pharma, pricing
MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the deadlock and …
AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes
June 11, 2019Manufacturing and Production, Research and Development AstraZeneca, diabetes, farxiga, pharma, type 2 diabetes
AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on …
Eli Lilly’s heart drug underwhelms with REWIND trial
June 11, 2019Manufacturing and Production Eli Lilly, Trulicity, pharma
Eli Lilly’s Trulicity (dulaglutide) reduced major cardiovascular events (MACE) by 12% versus placebo in adults with type 2 diabetes, according …
Three workers killed by explosion at pharma factory in India
June 11, 2019Manufacturing and Production China, India, explosion, manufacturing, pharma
Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …
Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma
June 11, 2019Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma
Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …
Insys Therapeutics files for bankruptcy
June 11, 2019Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma
Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …
Novartis Pharma head to become new Sanofi CEO
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
MSD scoops up biopharma firm Tilos for $773 million
June 10, 2019Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma
US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …
Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels
June 10, 2019Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes
Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …
Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials
June 10, 2019Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …
FDA advisory panel backs TB Alliance’s tuberculosis regimen
June 10, 2019Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis
An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …
Vectura CEO to step down at end of June
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura
Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …
Implementing “the safest medicines system in the world”
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma
With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …
Long-term BMS exec Johanna Mercier joins Gilead as new Chief Commercial Officer
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma
Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …
Novartis Pharma head to become new Sanofi CEO
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, Sanofi, appointment, olivier brandicourt, pharma
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
Marie-France Tschudin, head of Novartis subsidiary AAA, takes over from Paul Hudson as Novartis Pharma CEO
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Novartis has said Marie-France Tschudin will take over from Paul Hudson as the head of Novartis Pharmaceuticals. The announcement comes …
Top Ten most popular articles on Pharmafile.com this week!
June 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, EMA, Janssen, Orkambi, Pfizer
It was revealed this week that Pfizer suppressed findings that their anti-inflammatory Enbrel reduced the risk of Alzheimer’s by 64%. …
Mallinckrodt illegally inflated price of drug from $50 to $32,000, DoJ lawsuit says
June 7, 2019Business Services Achthar, DoJ, Mallinckrodt, Medicare, co-pay, pharma
The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
